University of Luebeck Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT03149900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Prof. Dr. med. Ingo Eitel